Susan L Way

Title: Celebrating the Innovations of Susan L. Way

Introduction: Susan L. Way, an inventive mind located in Danbury, Connecticut, has made significant contributions to the field of pharmaceuticals. Her innovative spirit is reflected in her work at Acorda Therapeutics, Inc., where she has developed a unique patent that addresses critical medical needs.

Latest Patents: Susan holds one patent for her invention titled "Sustained Release Compositions of 4-Aminopyridine." This groundbreaking patent focuses on sustained release tablets that include a core and a coating, designed for once-daily oral administration. This invention is particularly relevant for the treatment of neurological disorders, offering hope and convenience to patients.

Career Highlights: Throughout her career, Susan has been dedicated to advancing pharmaceutical innovations. Her work at Acorda Therapeutics, Inc. is a testament to her commitment to improving therapeutic options for patients affected by neurological conditions. The development of her patented composition illustrates her ability to merge scientific research with practical applications.

Collaborations: Susan has worked alongside notable colleagues, including Joseph E. Cobb, JR and Thomas B. Gold. These collaborations reflect a collective effort to drive innovation within the pharmaceutical industry, highlighting the importance of teamwork in advancing medical solutions.

Conclusion: Susan L. Way exemplifies the impact of inventors on healthcare through her innovative contributions. Her sustained release compositions of 4-aminopyridine serve as a reminder of the vital role that inventors play in developing therapies that improve patients' lives. As she continues her work at Acorda Therapeutics, Inc., Susan's legacy as an inventive leader in pharmacology is sure to inspire future innovators in the field.